PIG-A mutations in normal hematopoiesis

Blood

Volumn 105, Issue 10, 2005, Pages 3848-3854

  Hu, Rong ^b   Mukhina, Galina L ^b   Piantadosi, Steven ^b   Barber, Jamie P ^b   Jones, Richard J ^b   Brodsky, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AEROLYSIN; CD34 ANTIGEN; GENE PRODUCT; GLYCOSYLPHOSPHATIDYLINOSITOL; METHYLCELLULOSE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL GLYCAN CLASS A; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CELL DIFFERENTIATION; COLONY FORMING CELL; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENE MUTATION; GRANULOCYTE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOLECULAR CLONING; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PIG A GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STEM CELL; T LYMPHOCYTE;

EID: 18544381754     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1472     Document Type: Article

References (41)

1. Rosse WF. Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine. 1997;76:63-93.
2. Nishimura J, Murakami Y, Kinoshita T. Paroxysmal nocturnal hemoglobinuria: an acquired genetic disease. Am J Hematol. 1999;62:175-182.
3. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal hemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;126:133-138.
4. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711.
5. Bessler M, Mason PJ, Hillmen P, et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 1994;13:110-117.
6. Miyata T, Takeda J, Iida Y, et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993;259:1318-1320.
7. Pramoonjago P, Wanachiwanawin W, Chinprasertsak S, et al. Somatic mutations of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria. Blood. 1995;86:1736-1739.
8. Nafa K, Mason PJ, Hillmen P, Luzzatto L, Bessler M. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood. 1995;86:4650-4655.
9. Johnson RJ, Hillmen P. Paroxysmal nocturnal haemoglobinuria: nature's gene therapy? Mol Pathol. 2002;55:145-152.
10. Schrezenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel H. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol. 1995;23:81-87.
11. Nagarajan S, Brodsky RA, Young NS, Medof ME. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood. 1995;86:4656-4661.
12. Mukhina GL, Buckley JT, Barber JP, Jones RJ, Brodsky RA. Multilineage glycosylphosphatidylinositol anchor deficient hematopoiesis in untreated aplastic anemia. Br J Haematol. 2001;115:476-482.
13. Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999;131:401-408.
14. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988;69:413-418.
15. Rotoli B, Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Bailliere Clin Haematol. 1989;2:113-138.
16. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell. 1997;88:1-4.
17. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A. 1999;96:5209-5214.
18. Ware RE, Pickens CV, DeCastro CM, Howard TA. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes. Exp Hematol. 2001;29:1403-1409.
19. -, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood. 1995;86:1487-1492.
20. Kuick RD, Neel JV, Strahler JR, et al. Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in "spontaneous" germinal mutagenesis. Proc Natl Acad Sci U S A. 1992;89:7036-7040.
21. Abkowitz JL, Catlin SN, Guttorp P. Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med. 1996;2:190-197.
22. Kim HJ, Tisdale JF, Wu T, et al. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood. 2000;96:1-8.
23. Schmidt M, Zickler P, Hoffmann G, et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood. 2002;100:2737-2743.
24. Parker MW, van der Goot FG, Buckley JT. Aerolysin: the ins and outs of a model channel-forming toxin. Mol Microbiol. 1996;19:205-212.
25. Diep DB, Nelson KL, Raja SM, Pleshak EN, Buckley JT. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem. 1998;273:2355-2360.
26. Brodsky RA, Mukhina GL, Nelson KL, et al. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood. 1999;93:1749-1756.
27. Brodsky RA, Mukhina GL, Li S, et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol. 2000;114:459-466.
28. + hematopoietic stem cells. Mutat Res. 1999;431:183-198.
29. Brodsky RA, Vala MS, Barber JP, Medof ME, and Jones RJ. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. PNAS. 1977;94:8756-8760.
30. Oni SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood. 1970;36:145-152.
31. Josten KM, Tooze JA, Borthwick-Clarke C, Gordon-Smith EC, Rutherford TR. Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood. 1991;78:3162-3167.
32. Nishimura JJ, Hirota T, Kanakura Y, et al. Long-term support of hematopoiesis by a single stem cell clone in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2002;99:2748-2751.
33. Johnson RJ, Rawstron AC, Richards S, et al. Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells. Blood. 1998;91:4504-4508.
34. Abkowitz JL, Catlin SN, McCallie MT, Guttorp P. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood. 2002;100:2665-2667.
35. Nouspikel T, Hanawalt PC. DNA repair in terminally differentiated cells. DNA Repair (Amst). 2002;1:59-75.
36. Burman RW, Popovich BW, Jacky PB, Turker MS. Fully expanded FMR1 CGG repeats exhibit a length- and differentiation-dependent instability in cell hybrids that is independent of DNA methylation. Hum Mol Genet. 1999;8:2293-2302.
37. Jackson AL, Loeb LA. The mutation rate and cancer. Genetics. 1998;148:1483-1490.
38. Ostendorf T, Nischan C, Schubert J, et al. Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria. Blood. 1995;85:1640-1646,
39. Endo M, Ware RE, Vreeke TM, et al. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:2546-2557.
40. Noji H, Shichishima T, Saitoh Y, et al. The distribution of PIG-A gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts. Exp Hematol. 2001;29:391-400.
41. Kai T, Shichishima T, Noji H, et al. Phenotypes and phosphatidylinositol glycan-class A gene abnormalities during cell differentiation and maturation from precursor cells to mature granulocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2002;100:3812-3818.